TRERF1
From Wikipedia, the free encyclopedia
Transcriptional regulating factor 1, also known as TRERF1, is a human gene.[1]
This gene encodes a zinc-finger transcriptional regulating protein which interacts with CBP/p300 to regulate the human gene CYP11A1.[1]
[edit] References
[edit] Further reading
- Dorssers LC, Veldscholte J (1997). "Identification of a novel breast-cancer-anti-estrogen-resistance (BCAR2) locus by cell-fusion-mediated gene transfer in human breast-cancer cells.". Int. J. Cancer 72 (4): 700–5. PMID 9259413.
- Gizard F, Lavallée B, DeWitte F, Hum DW (2001). "A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.". J. Biol. Chem. 276 (36): 33881–92. doi: . PMID 11349124.
- Gizard F, Lavallee B, DeWitte F, et al. (2002). "The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells.". J. Biol. Chem. 277 (42): 39144–55. doi: . PMID 12101186.
- Gizard F, El-Alfy M, Duguay Y, et al. (2003). "Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expression.". Endocr. Res. 28 (4): 559–74. PMID 12530663.
- Mungall AJ, Palmer SA, Sims SK, et al. (2003). "The DNA sequence and analysis of human chromosome 6.". Nature 425 (6960): 805–11. doi: . PMID 14574404.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi: . PMID 14702039.
- Gizard F, Teissier E, Dufort I, et al. (2005). "The transcriptional regulating protein of 132 kDa (TReP-132) differentially influences steroidogenic pathways in human adrenal NCI-H295 cells.". J. Mol. Endocrinol. 32 (2): 557–69. PMID 15072559.
- Beausoleil SA, Jedrychowski M, Schwartz D, et al. (2004). "Large-scale characterization of HeLa cell nuclear phosphoproteins.". Proc. Natl. Acad. Sci. U.S.A. 101 (33): 12130–5. doi: . PMID 15302935.
- Gizard F, Robillard R, Barbier O, et al. (2005). "TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.". Mol. Cell. Biol. 25 (11): 4335–48. doi: . PMID 15899840.
- Gizard F, Robillard R, Gross B, et al. (2006). "TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.". Mol. Cell. Biol. 26 (20): 7632–44. doi: . PMID 17015480.